Perspective Therapeutics, Inc. — Director's Dealing 2012

Jul 9, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2012-06-27

Reporting Person: Babcock Dwight William (Director, CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-27	Stock Options	$0.98	P	50000	Acquired	2022-06-27	Common Stock (50000)	Direct

Footnotes

F1: (right to buy).